In an extraordinary move Friday, Abbott Laboratories immediately withdrew a major new antibiotic from the world market because of severe side effects, including three deaths. The drug, temafloxacin, has been marketed as Omniflox only since Feb. 1 in the United States. Marketed in 10 other ...